Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study

Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study

Abstract Background The impact of hepatic steatosis (HS) on treatment response following nucleos(t)ide analogue (NA) treatment for chronic hepatitis B (CHB) patients has not been clearly elucidated. We aimed to investigate the difference in HBeAg seroclearance between NA-treated HBeAg-positive CHB p...

Full description

Bibliographic Details
Main Authors: Yi-Cheng Chen, Wen-Juei Jeng, Chao-Wei Hsu, Chun-Yen Lin
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Gastroenterology
Subjects:
Chronic hepatitis B
Hepatic steatosis
HBeAg seroclearance
Nucleos(t)ide analogue treatment
Online Access:http://link.springer.com/article/10.1186/s12876-020-01289-w

Internet

http://link.springer.com/article/10.1186/s12876-020-01289-w

Similar Items